
Loubaba El Ayoubi
Stanford MS&E & Bioengineer | Venture Fellow at NFX | GTM @Inductive Bio
loubaba
Palo Alto, California, United States
Joined August 2025
Network
6.4K connectionsNBAMAD
MLMZHR
DVJMAF
LABBLR
APVOPF
AMSLAB
BBAL
Summary
Loubaba El Ayoubi is a highly driven individual with a strong academic background in engineering and a rapidly developing career in venture capital and biotech. She is pursuing a Master of Science in Management Science and Engineering at Stanford University, having previously completed an MEng in Biomolecular Engineering at Imperial College London. Her education underpins a keen interest in bio and health innovations. stanford+3
She possesses significant experience in the venture capital ecosystem, evidenced by her roles as a Venture Fellow at NFX, VC Healthtech Analyst at Kurma Partners, and VC Deep Tech Analyst at Elaia. Her involvement with baby vc as Head of UK and Healthcare Bootcamp Lead further highlights her commitment to fostering innovation and entrepreneurship within the healthcare and life sciences sectors. nfx+3
Loubaba is actively engaged in the intersection of engineering, AI, and biotechnology, holding positions such as ML Engineer | Research Assistant at SLAC National Accelerator Laboratory and GTM at Inductive Bio. This demonstrates her practical application of technical skills in cutting-edge research and commercialization within the biotech space. luma
She is also a participant in the prestigious Accel Leadership Program at Stanford, focusing on entrepreneurial leadership and real-world problem-solving within high-growth ventures, indicating a strong interest in leadership and startup strategy. stanford
Loubaba has contributed to written content, specifically two articles for baby vc's Healthcare & Life Sciences Masterclass Series, delving into topics like investing in therapeutic ventures and scaling digital health ventures, showcasing her analytical and communication skills in the health tech domain. substack+1
Work
Education
Writing
Investing in Therapeutic ventures
September 1, 2024An article exploring investment in therapeutic ventures, key investment drivers, business models, and trends as part of baby vc's Healthcare & Life Sciences Masterclass Series.
Scaling and Investing in Digital Health ventures
September 1, 2024An article discussing the critical points for scaling and investing in digital health ventures, presented as part of baby vc's Healthcare & Life Sciences Masterclass Series.